大博医疗收盘上涨1.45%，滚动市盈率38.61倍，总市值153.73亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Dabo Medical, indicating a recent stock price increase and a low rolling PE ratio compared to the industry average [1][2] - As of July 11, Dabo Medical's stock closed at 37.13 yuan, with a rolling PE ratio of 38.61, marking a new low in 21 days and a total market capitalization of 15.373 billion yuan [1] - The average PE ratio for the medical device industry is 52.06, with a median of 37.22, positioning Dabo Medical at the 80th rank within the industry [1][2] Group 2 - Dabo Medical's main business involves the production, research, and sales of high-value medical consumables, including a variety of orthopedic and surgical products [1] - The latest quarterly report for Q1 2025 shows Dabo Medical achieved a revenue of 550 million yuan, representing a year-on-year increase of 28.80%, and a net profit of 103 million yuan, reflecting a year-on-year growth of 67.04% with a gross profit margin of 69.64% [1]